R44-25489-23408
4 vaccinations
1 coded response
8 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2023-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-12
Dose 1 — Pfizer-BioNTech
-
2021-09-02
Dose 2 — Pfizer-BioNTech
-
2022-03-04
Dose 3 — Pfizer-BioNTech
-
2023-03-20
Registered in v-safe
-
2023-03-20
Dose 4 — Pfizer-BioNTech
- 2023-03-20
- 2023-03-22
- 2023-03-23
- 2023-03-25
- 2023-03-27
- 2023-04-05
-
2023-04-10
Survey response — day 21, dose 4MedDRA: Infection, Postpartum state — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-10
Report sent to call center — day 21, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-04-11
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-12 | Pfizer-BioNTech | No |
| 2 | 2021-09-02 | Pfizer-BioNTech | No |
| 3 | 2022-03-04 | Pfizer-BioNTech | No |
| 4 | 2023-03-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Infection | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release